Find Locations
For hours, walk-ins and appointments.Expected Turnaround Time
10 - 14 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Specimen Requirements
Specimen
Cerebrospinal fluid (CSF)
Volume
1.0 mL
Minimum Volume
0.5 mL
Container
Sterile screw capped vial
Collection
Collect entire sample into a single sterile tube. Immediately after collection, add a 2:1 ratio (acid:sample) of cold 8% perchloric acid. Vortex for 30 seconds, and place on ice for 5 minutes. Store frozen at -20°C and ship frozen.
Storage Instructions
Freeze as soon as possibe after collection.
Stability Requirements
Temperature | Period |
|---|---|
Room temperature | Unstable (stability provided by manufacturer or literature reference) |
Refrigerated | 24 hours (stability provided by manufacturer or literature reference) |
Frozen | -20°C = 72 hours; -80°C = Indefinite (stability provided by manufacturer or literature reference) |
Causes for Rejection
Bloody CSF; received thawed; sample received untreated
Test Details
Use
CSF Pyruvate is useful for investigating possible disorders of mitochondrial, metabolism, when used in conjunction with cerebrospinal fluid lactate collected at the same time to determine the Lactate:Pyruvate ratio. The CSF Lactate:Pyruvate ratio is considered a helpful (not diagnostic) tool in the evaluation of patients with possible disorders of mitochondrial metabolism, especially in patients with neurologic dysfunctin and normal blood Lactate:Pyruvate ratios. Pyruvic acid levels alone have little clinical utility. The Lactate:Pyruvate raio is elevated in several, but not all, mitochondrial respiratory chain disorders. Mitochondrial disorders vary widely in presentation and age of onset. Many mitochondrial disorders have neurologic and myopathic features and may involve multiple organ systems. Determination of lactate, pyruvate, and L:P ratio in cerebrospinal fluid is helpful in directing attention toward a possible mitochondrial disorder in cases with predominatly neurologic dysfunction and normal blood lactate levels. An elevated Lactate:Pyruvate ratio may indicate inherited disorders of the respiratory chain complex, tricarboxylic acid cycle disorders and pyruvate carboxylase deficiency. Respiratory chain defects usually result in Lactate:Pyruvate ratios >20. A low Lactate: Pyruvate ratio (disproportionately elevated pyruvic acid) may indicate an inherited disorder of pyruvate metabolism. Defects of the pyruvate dehydrogenase complex result in Lactate:Pyruvate ratios <10. The Lactate:Pyruvate ratio is characteristically normal in other patients. An artifactually high ratio can be found in acutely ill patients.
Limitations
This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.
Methodology
Enzyme/UV
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf